Arden Trust CO Charles River Laboratories International, Inc. Transaction History

Arden Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	SELL	$183.71 - $210.25 $223,575 - $255,874	-1,217 Reduced 51.03%	1,168 $245,000
Q1 2023 Apr 14, 2023	BUY	$191.89 - $259.92 $69,272 - $93,831	361 Added 17.84%	2,385 $481,000
Q4 2022 Jan 20, 2023	SELL	$197.11 - $250.07 $133,837 - $169,797	-679 Reduced 25.12%	2,024 $0
Q3 2022 Oct 20, 2022	BUY	$182.44 - $250.54 $54,549 - $74,911	299 Added 12.44%	2,703 $531,000
Q2 2022 Jul 12, 2022	BUY	$204.13 - $302.4 $75,936 - $112,492	372 Added 18.31%	2,404 $515,000
Q1 2022 Apr 11, 2022	BUY	$255.51 - $362.11 $55,190 - $78,215	216 Added 11.89%	2,032 $577,000
Q4 2021 Jan 24, 2022	BUY	$351.38 - $448.68 $638,106 - $814,802	1,816 New	1,816 $684,000

708

53.9M

122K

239K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.29B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.